Clinical Trial

Albumin in Acute Variceal Bleeding

Study acronym: ALB-AVB
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this randomized control clinical trial is to learn the role of albumin in patients with acute variceal bleed. The trial will include all adult patients with acute variceal bleeding and cirrhosis presenting to Medical Gastroenterology department at KGMU, Lucknow, U.P. India, will include patients with age between 18-70 years and all gender. The primary endpoint will be re-bleeding during hospitalization and at 6 weeks. Participants will be randomized in two groups, the intervention group will receive albumin for 3 days along with standard treatment and comparison group will receive on standard treatment.
Trial Details
NCT Number NCT07395141
Lead Sponsor King George's Medical University
Conditions Acute Variceal Bleeding, Cirrhosis
Enrollment 60 participants
Start Date 2026-03-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-09